Finch Therapeutics Group
FDA Fast-Tracks FMT Product for C. difficile
The FDA awarded a fast track designation for CP101, an encapsulated, oral fecal microbiota transplant product by ...
APRIL 2, 2018

Load more
The FDA awarded a fast track designation for CP101, an encapsulated, oral fecal microbiota transplant product by ...
APRIL 2, 2018